oliceridine [Ligand Id: 7334] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL2443262 (Oliceridine, Olinvyk, Olynvik, TRV-130, TRV130)
  • δ receptor/Delta opioid receptor in Human [ChEMBL: CHEMBL236] [GtoPdb: 317] [UniProtKB: P41143]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
  • κ receptor/Kappa opioid receptor in Human [ChEMBL: CHEMBL237] [GtoPdb: 318] [UniProtKB: P41145]
There should be some charts here, you may need to enable JavaScript!
  • μ receptor/Mu opioid receptor in Human [ChEMBL: CHEMBL233] [GtoPdb: 319] [UniProtKB: P35372]
There should be some charts here, you may need to enable JavaScript!
  • Nav1.5/Sodium channel protein type V alpha subunit in Human [ChEMBL: CHEMBL1980] [GtoPdb: 582] [UniProtKB: Q14524]
There should be some charts here, you may need to enable JavaScript!
  • Cav1.2/Voltage-gated L-type calcium channel alpha-1C subunit in Human [ChEMBL: CHEMBL1940] [GtoPdb: 529] [UniProtKB: Q13936]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
δ receptor/Delta opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL236] [GtoPdb: 317] [UniProtKB: P41143]
ChEMBL Agonist activity at human delta opioid receptor expressed in HEK293 assessed as increase in calcium mobilization incubated for 60 mins by FLIPR assay F 5 pEC50 >10000 nM EC50 Eur J Med Chem (2022) 228: 113986-113986 [PMID:34802839]
ChEMBL Agonist activity at human delta opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay F 5.55 pEC50 2800 nM EC50 J Med Chem (2013) 56: 8019-8031 [PMID:24063433]
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809]
ChEMBL Inhibition of human ERG channel expressed in HEK293 cells by whole-cell patch clamp technique B 5.21 pIC50 6200 nM IC50 J Med Chem (2013) 56: 8019-8031 [PMID:24063433]
κ receptor/Kappa opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL237] [GtoPdb: 318] [UniProtKB: P41145]
ChEMBL Agonist activity at human kappa opioid receptor expressed in HEK293 assessed as increase in calcium mobilization incubated for 60 mins by FLIPR assay F 5 pEC50 >10000 nM EC50 Eur J Med Chem (2022) 228: 113986-113986 [PMID:34802839]
ChEMBL Agonist activity at human kappa opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay F 5.85 pEC50 1400 nM EC50 J Med Chem (2013) 56: 8019-8031 [PMID:24063433]
μ receptor/Mu opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL233] [GtoPdb: 319] [UniProtKB: P35372]
ChEMBL Binding affinity to human mu opioid receptor by radio-ligand binding assay B 8.22 pKi 6 nM Ki J Med Chem (2013) 56: 8019-8031 [PMID:24063433]
ChEMBL Displacement of [3H]-Diprenorphine from human mu opiod receptor expressed in CHO cells incubated for 1 hr by competition binding assay B 8.84 pKi 1.46 nM Ki Eur J Med Chem (2022) 228: 113986-113986 [PMID:34802839]
ChEMBL Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as beta-arrestin recruitment by chemiluminescence assay B 7.3 pEC50 50.12 nM EC50 J Med Chem (2013) 56: 8019-8031 [PMID:24063433]
ChEMBL Agonist activity at mu opioid receptor (unknown origin) assessed as beta arrestin-2 recruitment incubated for 3 days by PathHunter assay F 7.92 pEC50 12 nM EC50 Eur J Med Chem (2022) 228: 113986-113986 [PMID:34802839]
ChEMBL Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay F 8.1 pEC50 8 nM EC50 J Med Chem (2013) 56: 8019-8031 [PMID:24063433]
ChEMBL Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay F 8.1 pEC50 7.94 nM EC50 J Med Chem (2013) 56: 8019-8031 [PMID:24063433]
ChEMBL Agonist activity at human mu opioid receptor expressed in HEK293 assessed as increase in calcium mobilization incubated for 60 mins by FLIPR assay F 8.17 pEC50 6.7 nM EC50 Eur J Med Chem (2022) 228: 113986-113986 [PMID:34802839]
ChEMBL Agonist activity at mu opioid receptor (unknown origin) assessed as increase in cAMP level incubated for 40 mins by spectrophotometry F 8.74 pEC50 1.8 nM EC50 Eur J Med Chem (2022) 228: 113986-113986 [PMID:34802839]
Nav1.5/Sodium channel protein type V alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1980] [GtoPdb: 582] [UniProtKB: Q14524]
ChEMBL Inhibition of human Nav 1.5 tonic ion channel expressed in HEK293 cells by whole-cell patch clamp technique B 4.78 pIC50 16500 nM IC50 J Med Chem (2013) 56: 8019-8031 [PMID:24063433]
ChEMBL Inhibition of human Nav 1.5 phasic ion channel expressed in HEK293 cells by whole-cell patch clamp technique B 5.33 pIC50 4700 nM IC50 J Med Chem (2013) 56: 8019-8031 [PMID:24063433]
Cav1.2/Voltage-gated L-type calcium channel alpha-1C subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1940] [GtoPdb: 529] [UniProtKB: Q13936]
ChEMBL Inhibition of human Cav 1.2 ion channel expressed in HEK293 cells by whole-cell patch clamp technique B 4.44 pIC50 36000 nM IC50 J Med Chem (2013) 56: 8019-8031 [PMID:24063433]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]